Showing results (1691-1700 of 1,881) with videos related to
Sort By:
Pageof 189
Immunotherapy|December 22, 2021
Dupilumab facial redness: histologic characterization on a series of four casesAgnieszka Dybała, Alvise Sernicola, Vito Gomes, et al.Immunotherapy|September 12, 2022
Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumorXuquan Jing, Hui Zhu, Yuying Li, et al.Immunotherapy|August 30, 2022
Overcoming immune-resistance in laryngeal cancer: a case report of the abscopal effect and nivolumab beyond progressionDe Felice Marco, Arrichiello Gianluca, Tammaro Mariagrazia, et al.Immunotherapy|September 1, 2022
Effect of neoadjuvant therapy on tumor tissue PD-L1 and VISTA expression levels in non-small-cell lung cancerOrhun Akdoğan, Osman Sütcüoğlu, Betül Öğüt, et al.Immunotherapy|February 14, 2022
A CD123-specific chimeric antigen receptor augments anti-acute myeloid leukemia activity of Vγ9Vδ2 T cellsXi Zhang, Wei Xia Ang, Zhicheng Du, et al.Immunotherapy|February 24, 2022
Targeted allergen-specific immunotherapy within the skin improves allergen delivery to induce desensitization to peanutJeffrey J Landers, Katarzyna W Janczak, Akhilesh Kumar Shakya, et al.Immunotherapy|May 16, 2019
Re-education of macrophages as a therapeutic strategy in cancerJoanna Kowal, Mara Kornete, Johanna A JoyceImmunotherapy|May 17, 2019
B-cell maturation antigen directed monoclonal antibody therapies for multiple myelomaErik Eckhert, Rhonda Hewitt, Michaela LiedtkeImmunotherapy|May 17, 2019
Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real lifeMarco Caminati, Alessandra Arcolaci, Massimo Guerriero, et al.Immunotherapy|May 17, 2019
Are mimotope vaccines a good alternative to monoclonal antibodies?Mona Pourjafar, Pouria Samadi, Hamed Manoochehri Khoshinani, et al.Pageof 189